Chest guidelines will create debate over which antiplatelet drug to add to aspirin after an acute coronary syndrome

New Chest guidelines will create debate over which antiplatelet drug to add to aspirin after an acute coronary syndrome.

These patients usually get clopidogrel (Plavix, etc)...but now guidelines suggest Brilinta (ticagrelor) over clopidogrel.

Brilinta is more effective...with a similar bleeding risk.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote